Rgenta Therapeutics Inc. Alternatives & Competitors
12 companies similar to Rgenta Therapeutics Inc. — We unlock the therapeutic potentials of highly disease-relevant targets undrugga...
Urovant Sciences
is part of Sumitomo Pharma America as of July 2023
Irvine, United States
Imuno Therapeutics
Identifying true targets in oncology and autoimmune disorders
Leiden, The Netherlands
Pear Bio
Patient-centered cancer precision medicine
London, United Kingdom
ViaNautis
Targeted Nanomedicines
Cambridge, United Kingdom
Track all Rgenta Therapeutics Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Zymeworks Inc.
Developing novel medicines for patients with difficult-to-treat cancers and other serious...
Canada
Rampart Bioscience
Leading a new era of effective, safe and accessible gene medicines.
Monrovia, United States
Orna Therapeutics
Wholly Owned Subsidiary of Eli Lilly and Company
Watertown, United States
Artios
Taking control of the DNA Damage Response (DDR)
Cambridge, United Kingdom
ITM Isotope Technologies Munich SE
Delivering the promise of radiopharmaceuticals to patients.
Germany
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
London, United Kingdom
Mustang Bio
A fortress biotech Company
Waltham, United States
About Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by small molecules.
Development of RNA-targeting small molecules, Oncology and CNS drug development, Gene and cell therapy innovation, RNA modulation platform research
Patients with hard-to-treat diseases, Medical researchers in oncology and neurology, Biotech partners for gene and cell therapy
RNA-targeting Medicines, Small Molecules, Oncology, Neurological Disorders, Genomics Data Mining, RNA Processing Events, Small-molecule Glues, Spliceosome Interactions, Regulatory Proteins, Therapeutic Development, Cambridge, Massachusetts, Undruggable Targets, Pharmaceutical Innovation, Disease-relevant Targets
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Rgenta Therapeutics Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Rgenta Therapeutics Inc. on 15 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.